• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology

    8/3/23 5:13:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care
    Get the next $ZJYL alert in real time by email

    CHANGZHOU, China, Aug. 3, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ:ZJYL) which is the world's leading provider of rehabilitation equipment. Currently, the Company's nanobathing products have been granted an invention patent and four utility model patents. Among them, one medical nanobathing care bed has obtained an invention patent, while a spray head mechanism and water nanobathing device, a water nanogenerator, a nanowater particle generation device, and a nanobathing care bed have received utility model patents. Furthermore, the Company has signed a directed procurement agreement for bed-type nanothermal therapy bath cabins with Shanghai Zhongjin HongKang Medical Technology Co., Ltd. This demonstrates JinMed's continuous upgrading of its nanothermal therapy products, showcasing the Company's research and development capabilities and the vast potential for future product development.

    Nanothermal therapy products have revolutionized the field with their remarkable ability to promote natural perspiration, enhance metabolism, provide deep nourishment, boost the body's natural healing abilities, and offer antibacterial and deodorizing effects. By combining the benefits of beauty and therapeutic bathing, these products introduce a new era of bathing care that emphasizes environmental sustainability and energy efficiency. They offer an unprecedented experience for long-term bedridden patients, the elderly, and postpartum women. What sets nanothermal therapy products apart is their ability to deliver an unparalleled bathing experience without the need for shower gel or rinsing, using only 1 liter of pure water. This completely overturns traditional bathing practices. These products release negative oxygen ions at concentrations of up to 180,000/cm3, while maintaining a temperature range of 38-42℃. Additionally, they continuously generate a significant amount of HSP (heat shock protein) to enhance the body's immune system, boost metabolism, and provide antibacterial and odor-eliminating effects. Moreover, nanothermal therapy products ensure superior safety and are suitable for individuals with weakened constitutions and the elderly to enjoy the benefits of thermal bathing.

    Nanothermal therapy products have also gained market recognition. Regarding the nanothermal therapy bath cabins and nanobathing devices, the Company has signed a directed procurement agreement with Shanghai Zhongjin HongKang Medical Technology Co., Ltd. This successful transition to the market reflects the market's trust in the Company.

    Since its establishment in 2006, JinMed has been committed to providing more comfortable, convenient, and safe products for the socially disadvantaged groups. With the increasing demand for medical products from consumers, in order to gain important development momentum, JinMed insists on research and development innovation, constantly launching more intelligent and portable medical devices, consolidating its business foundation, continuously expanding market share, and improving performance.

    About Jin Medical International Ltd.

    Founded in 2006 and headquartered at Changzhou City, Jiangsu Province of China, the Company, through its Chinese operating entities, designs and manufactures wheelchairs and living aids products for people with disabilities, the elderly, and people recovering from injuries. The Company's Chinese operating entities operate 2 manufacturing plants with approximately 228,257 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. The Company's Chinese operating entities have established relationships with over 40 distributors in China, and over 20 in the other regions of the world where it currently sells the products. The majority of the Company's wheelchair products, with more than 30 models, are sold to dealers in Japan and China, including Nissin Medical Industries Co., Ltd, one of the largest medical device distributors in Japan. The Company's Chinese operating entities own a number of patents with the Patent Administration Department of the People's Republic of China and aims to deliver innovative wheelchair designs that are both lightweight and ergonomic.

    For more information, please visit: http://www.zhjmedical.com.

    Cision View original content:https://www.prnewswire.com/news-releases/jinmeds-nanobathing-products-receive-multiple-patent-certifications-and-sign-directed-procurement-agreement-with-shanghai-zhongjin-hongkang-medical-technology-301892503.html

    SOURCE Jin Medical International Ltd

    Get the next $ZJYL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZJYL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZJYL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

    CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that its Board of Directors has approved an 1-for-20 share combination of all its authorized and issued ordinary shares (the "Stock Combination") pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 30, 2026 (the "EGM"). Effective as of the date of the EGM, the Company's authorized share capital is reclassified into a dual class of Class A ordinary shares

    3/11/26 7:30:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical CEO Fireside Chat

    CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat on February 2, 2026 where the CEO shared some insights into the Company's recent strategic priorities and long-term growth considerations. The following questions were prepared by the Company and addressed by the Company's CEO, Dr. Erqi Wang during the conversation. Certain statements made during the discussion were forward-looking, and the Company provided a cautionary note regarding forward-looking statements prior to the start of th

    2/5/26 8:57:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical International Ltd. To Host Management Fireside Chat

    CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, announced today that its Chief Executive Officer, together with the Company's management team, will host a fireside chat at 8:00 pm EST on February 1, 2026. The discussion will provide insights into the Company's recent strategic priorities and long-term growth considerations. The Company also announced the launch of its updated corporate website at http://www.jinmed.com, where the fireside chat will be webcast. About Jin Medical International Ltd. Fo

    1/26/26 8:57:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    SEC Filings

    View All

    SEC Form 20-F filed by JIN MEDICAL INTERNATIONAL LTD.

    20-F - Jin Medical International Ltd. (0001837821) (Filer)

    2/9/26 8:55:46 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    2/9/26 4:40:26 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    2/4/26 8:30:21 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    Financials

    Live finance-specific insights

    View All

    Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

    CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.Revenues from whee

    8/23/23 4:15:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care